Glaxosmithkline | Passivo Circulante



Current Liabilities Alterar Data
AbbVie USD 38.75B 4.31B 2024-12
Amgen USD 23.01B 91M 2025-03
AstraZeneca USD 29.13B 1.26B 2025-03
Aurora Cannabis CAD 149.81M 40.71M 2024-12
Bausch Health Companies USD 4.26B 2.5B 2025-03
Bristol-Myers Squibb USD 24.07B 296M 2025-03
Canopy Growth CAD 97.02M 184.27M 2024-12
Corcept Therapeutics USD 143.07M 2.29M 2025-03
Drreddys Laboratories INR 131.95B 2.65B 2024-12
Eli Lilly USD 30.07B 1.69B 2025-03
GlaxoSmithKline GBP 20.83B 866M 2025-03
Glaxosmithkline GBP 21.7B 238M 2024-12
Indivior 1.01B 66M 2025-03
J&J USD 56.9B 6.58B 2025-03
Merck USD 25.17B 3.25B 2025-03
Novartis USD 28.69B 560M 2024-12
Pacira USD 314.73M 4.81M 2025-03
Perrigo USD 1.07B 29.6M 2025-03
Pfizer USD 36.45B 6.54B 2025-03
Prestige Brands USD 106.62M 4.08M 2025-03
Roche Holding CHF 27.02B 424M 2024-12
Sanofi 32.22B 3.06B 2025-03
Supernus Pharmaceuticals USD 292.4M 889K 2024-12
Takeda JPY 2.51T 408.56B 2025-03
Teva Pharmaceutical Industries USD 11.16B 1.64B 2025-03
Zoetis USD 3.38B 27M 2025-03



Glaxosmithkline Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.